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Abstract
Background: p8 is a DNA-binding protein induced in many tissues in response to LPS treatment.
Hence, p8 could be a mediator of LPS-associated effects or, on the contrary, p8 expression may be
part of the protective mechanism of the tissues in response to LPS. Finally, p8 expression in
response to LPS could also be a simple epiphenomenon.
Methods: To investigate the role of p8 in vivo, we generated p8-deficient mice by gene targeting.
Because p8 is a stress protein, we analyzed the response of p8-/- mice to a systemic stress induced
by LPS injection. Liver was chosen as model organ to monitor alterations in gene expression.
Results: LPS resulted in higher serum TNF-α concentration and higher mortality rate in p8-
deficient mice than in wild-type. Also, liver and pancreas, but not lung, from p8-/- mice showed
increased amounts of MPO and HPO. To gain insight into the molecular bases of such susceptibility,
we used high density DNA microarrays consisting of ~6000 genes and ESTs to compare gene
regulation in response to LPS in p8+/+ and p8-/- livers. In wild-type, 105 genes and 73 ESTs were up-
regulated and 232 genes and 138 ESTs down-regulated. By contrast, 212 genes and 125 ESTs were
found up-regulated and 90 genes and 85 ESTs down regulated in p8-/- mice. Among them, only 93
(51 induced and 42 repressed) corresponded to the wild-type pattern, demonstrating that p8
deficiency hinders the normal response to LPS, which may account for the increased sensitivity of
p8-/-mice to the endotoxin.
Conclusions: The large number of genes showing abnormal regulation after LPS suggests that p8
is an important regulatory factor involved in many cellular defence pathways.
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Background
Using a systematic approach, we identified a new gene,
called p8, whose expression is strongly induced during the
acute phase of pancreatitis [1]. The deduced protein
sequence revealed that p8 was an 80 aminoacid polypep-
tide whose primary structure could not be aligned with
any of the protein sequences present in public databases.
By contrast, p8 contains a canonical bipartite signal for
nuclear targeting suggesting that p8 should be located in
the nucleus. Supporting this hypothesis we detected p8
within the nucleus of Cos-7 cells transfected with a p8
expression plasmid, although it was also partly located to
the cytoplasm [2]. Furthermore, analysis of p8 primary
structure suggested that it should be a DNA-binding pro-
tein [1]. More recently, we performed biochemical and
biophysical studies showing that human recombinant p8
was in many structural aspects very similar to the "high
mobility group" (HMG) proteins, although sharing with
them little aminoacid sequence homology [3]. In addi-
tion, p8 binding to DNA, rather weak with the native pro-
tein, was strongly enhanced after phosphorylation by PKA
of serine/threonine residues [3]. HMG protein binding to
DNA is also regulated by post-translational modifications
[4]. Thus, in spite of a lack of significant sequence homol-
ogy, p8 can be considered as a HMG-like protein. It is
interesting to note that HMG1, a member of the HMG
family of proteins, is a potent pro-inflammatory mediator
released passively by necrotic cells but not by apoptotic
cells [reviewed in [5]].
Further experiments have shown that p8 activation is not
restricted to pancreatic cells. In vivo, p8 mRNA is activated
in several tissues in response to systemic lipopolysaccha-
ride (LPS) treatment [6] and in vitro studies showed that a
variety of cell lines exhibited transient p8 mRNA expres-
sion in response to stress [1,2]. p8 is therefore an ubiqui-
tous protein induced by cellular stress which may be part
of a general defence program against cellular injury or cel-
lular stress. Concomitant studies by another laboratory
[7] revealed that expression of the candidate of metastasis 1
(Com 1) protein, which is identical to human p8 [2],
mediates the growth of tumour cells after metastatic estab-
lishment in a secondary organ, suggesting that activated
expression of p8 in metastatic cells is required for tumour
progression and this hypothesis was recently confirmed
[8]. Also, overexpression of p8 in certain cell lines pro-
motes growth [1,2] but it can also inhibit growth when
recruited by inhibitory signals [9]. Taken together, these
results suggest that p8 expression may regulate many cel-
lular functions, in response to cellular injury or during
tumour development, and that p8 may play different roles
depending on the cell type and/or growth conditions.
In response to stress, cells activate various intracytoplas-
mic pathways, depending on cell type and nature of the
stress agent, that ultimately send to the nucleus signals
that modulate gene expression. The new pattern of gene
expression will help the cells resist the injury and, in case
of systemic stress, the efficacy of the defence programs will
condition the survival of the organism. Since p8 is acti-
vated in several tissues in response to LPS treatment [6],
this molecule is a putative mediator of a protective
response. To investigate this hypothesis, we have created
by targeted disruption mice lacking the p8 gene. p8-/- mice
showed normal development, they were fertile and their
life-span was similar to that of wild type. However, DNA
microarray analysis of gene expression in their liver
showed important modifications, suggesting that their
stress-response capacity could also be altered. Indeed,
their mortality rate after LPS challenge was significantly
increased compared to wild-type. LPS induced drastic
changes in their pattern of gene expression in liver. Inter-
estingly, that pattern was very different from the pattern
induced by LPS in wild-type liver, which corresponds to
the normal stress response. It was concluded that p8 is
required for adequate response to LPS-induced injury.
Results
Targeted disruption of the p8 gene creates a null mutation
To investigate the function of p8, a null allele was gener-
ated in 129/Sv embryonic stem (ES) cells by replacing
exon 2 of the p8 gene, which encodes 60% of the coding
sequence, with a neomycin-resistance cassette. Germline
transmission was obtained after injection of these ES cells
into C57BL/6 blastocysts. Then, we intercrossed mice het-
erozygous (p8+/-) for the targeted disruption to produce
homozygous offspring (p8-/-). These crosses provided lit-
ters of normal size, with living, apparently normal p8-/-
offspring occurring with a frequency consistent with Men-
delian inheritance. p8 deficiency was verified by RT-PCR
and/or Southern blot analysis and by immunostaining of
the pancreas with acute pancreatitis with a p8 polyclonal
antibody (data not shown). Given these results and the
extensive nature of the deletion, we concluded that the p8
mutation was null. Details about production of p8-/- mice
should be obtained from authors upon request.
LPS sensitivity of p8-deficient mice
p8 was initially defined as a gene activated in several tis-
sues in response to LPS treatment [6]. Hence, p8 could be
a mediator of LPS-associated effects or, on the contrary, p8
expression may be part of the protective mechanism of the
tissues in response to LPS. p8 expression in response to
LPS could also be a simple epiphenomenon. In this study,
we analyzed whether p8 knockout mice would display
altered reactivity to LPS. Groups of 20 mice each were
injected with 70 mg/kg and lethality was monitored. As
shown in Figure 1, 70% of p8-/- mice died 36 hours after
LPS treatment, compared to only 20% of p8+/+ mice. After
5 days 50% of p8+/+ and 20% of p8-/- survived. Thus, wild-BMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/25
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type mice tolerated LPS treatment better than p8-/- mice.
We monitored in parallel the serum levels of three
cytokines. If levels of interferon γ (IFNγ) and the anti-
inflammatory cytokine IL-10 were not different in p8-/-
and p8+/+ mice (data not shown), the level of TNF-α was
significantly higher in p8-/- mice (Figure 2), supporting the
hypothesis that p8 expression provides some protection
against LPS aggression. Finally, whether liver or pancreas
could be differently affected by LPS challenge depending
on the p8 status was evaluated by monitoring serum levels
of GOT and amylase. No difference was observed (data
not shown). Although these markers are not very sensi-
tive, these results suggest that, in these two organs, lack of
p8 expression does not increase markedly LPS-induced
cell damage.
Myeloperoxidase (MPO) and hydroperoxide (HPO) in 
lung, liver and pancreas after LPS treatment
LPS is known to induce a systemic inflammatory syn-
drome characterized by strong leucocytic infiltration and
free radical production which may be lethal [10]. To
investigate the role of p8 expression during LPS treatment
we monitored MPO activity, as an indicator of tissue infil-
tration, and HPO concentration as an indicator of free
radical production, known to correlate with the intensity
of lesions. In control mice, liver, lung and pancreas
showed increased MPO activity and HPO concentration
after LPS injection, as expected (Figures 3, 4 and 5). In p8-
/- mouse lungs, the kinetics of changes in MPO activity and
HPO were the same as in wild-type mice (Figure 3). They
were however very different in pancreas and liver, show-
ing that p8 influence could vary among tissues. In liver
from control mice, MPO activity increased sharply to a
maximum already reached 6 hours after LPS injection,
then dropped by 65% in the next 6 hours and decreased
more progressively thereafter (Figure 4), indicating that
liver recruited leucocytes for transient infiltration. In liver
from p8-deficient mice, MPO activity increases progres-
sively with a maximum at 18 hours suggesting that the
mechanism of leucocyte recruitment was either altered or
different from wild-type. Contrary to MPO activity, HPO
production was similar in p8+/+ and p8-/- mouse livers.
This is not surprising since HPO is produced by Kupffer
cells [11] which are specialized macrophages residing in
the liver. In pancreas from control mice, changes in MPO
Lipopolysaccharide (LPS)-induced mortality in 129/Sv wild- type and 129/Sv-backcrossed p8-deficient knockout mice Figure 1
Lipopolysaccharide (LPS)-induced mortality in 129/Sv wild-
type and 129/Sv-backcrossed p8-deficient knockout mice. 
Groups (n = 20) of female mice were injected intraperito-
neally with 70 mg/kg LPS (Salmonella thyphosa), and survival 
was monitored every 12 hours for 5 days.
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Wild-type and p8-deficient mice were injected intraperito- neally with 70 mg/kg LPS (Salmonella thyphosa), and serum  samples were harvested after diferent times Figure 2
Wild-type and p8-deficient mice were injected intraperito-
neally with 70 mg/kg LPS (Salmonella thyphosa), and serum 
samples were harvested after diferent times. TNF-α levels 
were determined by ELISA. Errors bars represent the stand-
ard deviation (n = 6).
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and HPO followed the same pattern, i.e. transient increase
with maximum 12 hours after LPS injection followed by
decrease towards control values. In p8-deficient mice,
both MPO activity and HPO concentration remained ele-
vated after 12 hours (Figure 5) underscoring the role of p8
in the regulation of infiltration and free radical produc-
tion. Taken together, these results suggest that p8 contrib-
utes to the tissue response to LPS, such response being
different in pancreas, liver and lung.
Gene expression in liver analyzed by DNA microarray
Liver was chosen as a target tissue of the LPS to decipher
the role p8 in constitutive gene expression and in the
response to LPS. We compared the expressions of ~6,000
Wild-type and p8-deficient mice were injected intraperito- neally with 70 mg/kg LPS (Salmonella thyphosa), and Mye- loperoxidase (MPO) activity and Hydroperoxide (HPO)  concentration were measured in lung after 6, 12, 18 and 24  hours Figure 3
Wild-type and p8-deficient mice were injected intraperito-
neally with 70 mg/kg LPS (Salmonella thyphosa), and Mye-
loperoxidase (MPO) activity and Hydroperoxide (HPO) 
concentration were measured in lung after 6, 12, 18 and 24 
hours. Errors bars represent the standard deviation (n = 7).
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Wild-type and p8-deficient mice were injected intraperito- neally with 70 mg/kg LPS (Salmonella thyphosa), and Mye- loperoxidase (MPO) activity and Hydroperoxide (HPO)  concentration were measured in liver after 6, 12, 18 and 24  hours Figure 4
Wild-type and p8-deficient mice were injected intraperito-
neally with 70 mg/kg LPS (Salmonella thyphosa), and Mye-
loperoxidase (MPO) activity and Hydroperoxide (HPO) 
concentration were measured in liver after 6, 12, 18 and 24 
hours. Errors bars represent the standard deviation (n = 7).
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different genes in liver from p8+/+ and p8-/- mice, without
treatment and 12 hours after an intraperitoneal injection
of LPS.
Gene expression in livers from p8+/+ and p8-/- mice
The gene expression pattern of p8-/- mouse liver was com-
pared to that of wild-type, in basal conditions, using DNA
microarray analysis. Only genes whose expression dif-
fered by a factor ≥ 2 were considered (Tables 1 and 2 [see
Additional file 1]). Of the ~6,000 known genes and ESTs
monitored, 156 (2.6%) showed consistent differences. As
control, expression of several genes chosen at random was
measured by RT-PCR analysis and results confirmed
microarray data (not shown). In p8-/- liver, the expression
of 78 known genes and 33 ESTs (1.85%) was lowered (by
a factor of 2 to 8), and that of 25 known genes and 20 ESTs
(0.75%) was increased (by a factor of 2 to 11.1) compared
to wild-type. Of the 78 known genes down-regulated as a
result of p8 deficiency, 14 were implicated in protein syn-
thesis, transport or post-translation modifications, 11
were implicated in signaling, 7 coded for secretory factors
and 2 for cytoskeletal proteins, 13 were transcription fac-
tors or involved in RNA processing, 3 coded for apoptosis-
related proteins, 7 corresponded to membrane or trans-
porter proteins, 17 to cytosolic enzymes or detoxification
factors, and 4 were proteins implicated in cell growth.
Among genes up-regulated as a consequence of p8 defi-
ciency, 6 corresponded to signaling molecules, 4 coded
for secretory factors, 3 for cytoskeletal proteins, 5 for tran-
scription factors or for proteins involved in RNA process-
ing, 1 was apoptosis-related, 4 corresponded to
membrane and transporter proteins and 2 were cytosolic
enzymes. The list of ESTs up- or down-regulated by a fac-
tor of at least 2 is available at http://www.mar
seille.inserm.fr/Site_INSERM/emi0116/resultsESTs.htm.
Gene expression in liver after LPS treatment
Pure SV129J mice were treated with 70 mg/kg of LPS from
Salmonella thyphosa and gene expression in the liver was
compared to expression in the liver of mice injected with
saline. Expression of 105 known genes (1.77%) and 73
ESTs (1.22%) was up-regulated (by a factor of 2 to 62.3)
whereas expression of 232 (3.87%) known genes and 138
ESTs (2.30%) was down-regulated (by a factor from 2 to
68.3). Known genes up-regulated by LPS treatment were
grouped as follows: 4 genes coded for proteins implicated
in protein synthesis, transport or post-translational mod-
ifications, 17 for proteins involved in signaling, 23 genes
corresponded to secretory factors, 5 to cytoskeletal pro-
teins, 27 to transcription factors or molecules involved in
RNA processing, 1 gene coded for an apoptosis-related
protein, 19 corresponded to membrane or transporter
proteins, 5 to cytosolic enzymes and detoxification fac-
tors, and 4 were implicated in cell growth. Among known
genes down-regulated as consequence of LPS treatment,
23 were implicated in protein synthesis, transport or post-
translational modifications, 34 corresponded to signaling
molecules, 16 were secretory factors, 7 coded for cytoskel-
etal proteins, 20 for transcription factors and RNA
processing proteins, 5 coded for apoptosis-related pro-
teins, 31 corresponded to membrane or transporter pro-
teins, 79 to cytosolic enzymes or detoxification factors,
Wild-type and p8-deficient mice were injected intraperito- neally with 70 mg/kg LPS (Salmonella thyphosa), and Mye- loperoxidase (MPO) activity and Hydroperoxide (HPO)  concentration were measured in pancreas after 6, 12, 18 and  24 hours Figure 5
Wild-type and p8-deficient mice were injected intraperito-
neally with 70 mg/kg LPS (Salmonella thyphosa), and Mye-
loperoxidase (MPO) activity and Hydroperoxide (HPO) 
concentration were measured in pancreas after 6, 12, 18 and 
24 hours. Errors bars represent the standard deviation (n = 
7).
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and 17 corresponded to growth-related factors. Results are
shown in Tables 3 and 4 [see Additional file 2]. The list of
ESTs up- or down-regulated by LPS by a factor of at least 2
is available at http://www.marseille.inserm.fr/
Site_INSERM/emi0116/resultsESTs.htm.
Gene expression in p8-/- liver after LPS treatment
Effect of LPS treatment on liver gene expression was also
analyzed in p8-/- mice. Results are presented in Tables 5
and 6 [see Additional file 3]. Five hundred and twelve
(8.53%) showed consistent changes in expression level of
at least 2-fold. Expression of 212 known genes and 125
ESTs (2.08%) was up-regulated (by a factor of 2 to 50.0),
and 90 known genes and 85 ESTs (1.42%) were down-reg-
ulated (by a factor of 2 to 29.9). Among up-regulated
genes, 30 coded for proteins implicated in protein synthe-
sis, transport or post-translation modifications, 45 for
genes involved in signaling, 22 corresponded to secretory
factors, 16 to cytoskeletal proteins, 34 to transcription fac-
tors and RNA processing molecules, 7 genes encoded
apoptosis-related proteins, 34 corresponded to mem-
brane or transporter proteins, 13 to cytosolic enzymes or
detoxification factors, and 11 to proteins implicated in
cell growth. Among down-regulated genes, 1 coded for a
mitochondrial stress protein, 8 corresponded to signaling
molecules, 10 to secretory factors, 3 to cytoskeletal pro-
teins, 9 encoded transcription factors or proteins involved
in RNA processing, 1 to an apoptosis-related protein, 10
corresponded to membrane or transporter proteins, 45 to
cytosolic enzymes and detoxification factors, and 3
corresponded to growth-related factors. To be physiologi-
cally relevant, modifications in gene expression observed
in p8-/- liver after LPS have to be significant compared to
normal wild-type liver (e.g.: a gene down-regulated by a
factor of 2 in p8-/-, compared to wild-type, must be up-reg-
ulated at least 4 times after LPS to be physiologically sig-
nificant). Interestingly, it was indeed the case for more
than 90% of genes up-regulated and 99% of genes down
regulated after LPS. ESTs up- or down-regulated by LPS in
p8-/-  liver by a factor of at least 2 are available at
http:www.marseille.inserm.fr/Site_INSERM/emi0116/
result sESTs.htm.
Comparison of LPS-induced gene regulations in p8+/+ and 
p8-/- livers
If the total number of genes with significantly altered
expression after LPS was similar in p8+/+ and p8-/- livers,
the regulatory patterns were very different. Twice more
genes were upregulated in p8-/- than in p8+/+ mice (337 vs.
178), the proportion being reversed for down-regulated
genes (175 vs. 370). Among known genes, only 51 and 42
were up- and down-regulated, respectively, in both p8+/+
and p8-/- livers. More strikingly, several genes were oppo-
sitely regulated, including 19 genes down-regulated in
p8+/+ but up-regulated in p8-/- liver and one gene up-regu-
lated in p8+/+ but down-regulated in p8-/- liver, which
underscores the differences between LPS-induced gene
regulation patterns in p8+/+ and p8-/- livers.
HMG1 expression in liver after LPS treatment
Finally, because the effects of HMG1 and p8 seem to be
opposite (e.g.: HMG1 play a pro-inflammatory role
whereas p8 acts as an anti-inflammatory factor), we
analyzed in detail expression of HMG1 mRNA by semi-
quantitative RT-PCR. Contrary to the HMG-related pro-
teins HMG-I(Y) and p8 which are activated in liver by LPS
treatment, HMG1 mRNA expression remains unchanged
after 6 and 18 hours (Figure 6). This is in fact not a sur-
prise since HMG1 expression in liver by LPS seems to be
activated by 2–3 folds within the first 2 hours following
LPS treatment, returning to the untreated value thereafter
[12]. Another important difference to be noted is that
whereas p8-/- mice were normal, HMG1-/- pups are born
alive, but die within 24 hours due to hypoglycemia [13].
Wild-type mice were injected intraperitoneally with 70 mg/ kg LPS (Salmonella thyphosa), and mRNA expression was  measured in liver after 6 and 18 hours Figure 6
Wild-type mice were injected intraperitoneally with 70 mg/
kg LPS (Salmonella thyphosa), and mRNA expression was 
measured in liver after 6 and 18 hours. RNA was extracted 
using Trizol procedures and 1 µg RNA was analyzed by RT-
PCR using specific primers for HMG1, p8 and ribosomal pro-
tein L3 (RL3) as a control as described in Material and 
Methods.BMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/25
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Discussion
We constructed a p8-/- mouse as a tool to investigate the
function of the p8 gene. p8-deficient mice were fertile,
developed normally and showed no obvious signs of
disease up to 20 months of age. These findings imply
either that p8 is not involved in crucial developmental
processes or that other genes are functionally redundant.
However, p8-deficient mice were more sensitive to the
noxious effects of LPS, as evidenced by decreased survival
(Figure 1), increased levels of serum TNF-α (Figure 2) and
higher levels of MPO and HPO in some tissues (Figure 3,
4 and 5), compared to wild-type, which suggests the
implication of p8 in important defence mechanisms.
Because p8 is biochemically related to HMG-I(Y) proteins
[3], which play a critical role in architectural changes of
DNA to modulate gene expression [14–17], we made the
hypothesis that, under conditions of stress, p8 regulates
gene expression to improve cell resistance. Lack of p8
expression would therefore prevent adequate stress
response with, as consequence, increased mouse
mortality. Liver was chosen as model organ to test that
hypothesis, because it is known that LPS triggers in that
organ important changes in the expression of several
genes [18,19]. To analyze in p8-/- mice how the lack of p8
might alter liver response to LPS, we documented by
microarray DNA studies the pattern of gene expression in
p8-/-  liver, for comparison with wild-type, then the
response of wild-type liver to LPS for eventual comparison
with p8-/- liver.
Gene expression is altered in p8-/- liver
As speculated, the pattern of liver gene expression was
strongly altered as a consequence of p8 gene disruption.
Compared to wild-type, 156 genes (2.6%) showed signif-
icant changes in their expression (111 repressed and 45
induced). Therefore, many genes are either directly
dependent on p8 for adequate expression, or indirectly
modulated in response to perturbations resulting from its
absence. p8 seems to be preferentially, but not exclusively,
a positive regulator since more than two thirds of the
genes were down-regulated in the p8-/- liver. Interestingly,
p8 interferes with most cellular functions since genes
altered upon p8 disruption were involved in transcription
and RNA processing, protein synthesis, transport and
post-translational modification, apoptosis, regulation of
cell growth, intracellular signaling, or encoded secretory
or cytoskeleton proteins, membrane and transporter pro-
teins, cytosolic enzymes and detoxification factors.
Liver response to LPS is altered in p8-/- mice
Modulation by LPS of liver gene expression was first
assessed in wild-type mice. Among the ~6000 known
genes and ESTs of the microarray, 548 (9.1%) showed sig-
nificant change (at least twofold) in their expression. Up-
regulation was observed for 178 genes, whereas 370 genes
were down-regulated. As shown in Tables 3 and 4 [see
Additional file 2], genes implicated in all major intracellu-
lar pathways are involved in the liver response to LPS.
Such a wide spectrum of changes after endotoxin treat-
ment was already reported in other tissues [20–22].
Although the influence of LPS on liver is not the main
objective of this work, it is noteworthy that many interest-
ing genes are found strongly up-regulated (e.g.: proteas-
ome subunits, PAI-I, MIG, mag-1, Scya 5) or down-
regulated (EGF receptor-binding protein, MHL-1, IL-6
receptor), underscoring that LPS had triggered a very elab-
orate response.
In p8-/- mice, liver gene expression was also strongly mod-
ified by LPS. To our surprise, the total number of genes
with altered expression was almost the same as in wild
type (512 vs. 548). However, only 93 of them (1.55%),
because they show the same regulation (up- or down) as
in wild-type, would be regulated after LPS challenge
through p8-independent pathways. Therefore, a large
number of genes whose regulation is part of the normal
response to LPS could not be properly modulated in p8-/-
mice. Because these genes are involved in major cellular
functions (Tables 3, 4, 5 and 6 [see Additional files 2 and
3), such alteration could be partly responsible for the
increased sensitivity of p8-/- mice to LPS, inasmuch as
other organs should be similarly affected. Some genes
previously reported as protective against LPS challenge,
such as GARG-16 [23], SAA5 [24] and SOD3 [25] were
actually found overexpressed after LPS in wild-type but
not in p8-/- livers. Other genes identified in this systematic
study could therefore lead to novel therapeutic strategies
in endotoxin-mediated pathologies.
In addition to preventing adequate regulation of many
genes involved in the normal response to LPS, lack of p8
perturbated the expression of a large number of other
genes, which were improperly up- or down-regulated.
These genes belonging to many cellular pathways, further
intracellular perturbations are expected which may
amplify the noxious consequences of LPS administration.
Among genes specifically activated by LPS in p8-deficient
liver, the chromatin nonhistone high mobility group pro-
tein HMG-I(Y) gene (accession # J04179) was of particu-
lar interest because the corresponding proteins are
structurally and biochemically similar to p8, which sug-
gests similar functions [[3] and unpublished results]. In
response to LPS, expression of p8 is strongly overex-
pressed in liver [6] whereas HMG proteins are not acti-
vated (Table 3 [see Additional file 2]). Yet, in p8-deficient
mouse liver, the HMG-I(Y) protein was activated 8.5 fold,
which may reflect a compensatory mechanism. These
results strongly suggest that p8, which is probably a tran-
scription factor [26], is a key regulatory gene in the cellular
response to LPS. If its absence is apparently withoutBMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/25
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important consequences in normal conditions, it prevents
mice from fully developing their defence program against
LPS challenge.
In conclusion, this work demonstrates that p8 overex-
pressed in response to LPS is not a mediator of tissue
insult but rather an important component of a defence
program. Microarray DNA analysis of liver gene expres-
sion demonstrated the crucial role of the protein in the
regulation of important cellular pathways. If the technical
limitation of that analysis to roughly one fifth of the
genome prevented thorough description of the p8 path-
way, the information gathered should provide ground for
many further studies concerning p8 function and the cel-
lular response to endotoxin challenge.
Methods
Targeted disruption of the mouse p8 gene
The construction of the targeting vector used in the tar-
geted disruption of the p8 locus in embryonic stem cells
of mouse strain 129/Sv was previously reported by Kuh-
bandner et al. [27]. ES cells from three heterozygous
clones for the mutated p8 allele were injected into blasto-
cysts of C57BL/6 mice. We obtained in the littermates 7
male mice highly chimerical. They were intercrossed with
wild-type C57BL/6 females and 4 showed germline trans-
mission. Genotype identification was done by PCR and/
or Southern blot with genomic DNA prepared from tail
biopsies of 10 day-old mice. Heterozygous mice for the
mutated p8 allele were obtained and used in breeding
experiments to generate mice homozygous (-/-) for the dis-
ruption of p8. p8-deficient mice were backcrossed to
SV129J mice for nine generations as recently described
[28].
Lipopolysaccharide toxicity in vivo
Mice were housed in rooms maintained at constant tem-
perature and humidity and subjected to a 12-h light/dark
cycle. Mice received normal rodent chow (Purina, St.
Louis, MO) and water ad libitum. Three months old
females were used. Animals (p8+/+ and p8-/-) were injected
intraperitoneally with 70 mg/kg of LPS (Salmonella thy-
phosa, Sigma) resuspended in sterile saline. This dose of
LPS was chosen on the basis of preliminary studies in
wild-type 129/Sv mice in which the dose resulted in less
than 50% mortality. Deaths were recorded every 12 hours,
and mice that survived 5 days had fully recovered and
were considered as long-term survivors.
Serum GOT and amylase measurements
Amylase and GOT activities were determined with com-
mercially available assays kits from Roche Biochemicals
and Sigma Diagnostics respectively following manufac-
turer recommendations.
Determination of TNF-α
For determination of TNF-α release kinetics in serum,
mice were killed at the indicated time points after treat-
ment, and serum samples were harvested. TNF-α serum
level was determined with a commercially available
enzyme-linked immunoabsorbent assay (ELISA) kit (R&D
Systems).
Myeloperoxidase assay
Myeloperoxidase was measured photometrically with
3,3',5,5'-tetramethylbenzidine as substrate as previously
described [29]. Samples were macerated with 0.5% hexa-
decyltrimethylammonium bromide in 50 mM phosphate
buffer pH 6.0. Homogenates where then disrupted for 30
s using a Labsonic (B Braun) sonicator at 20% power and
submitted to three cycles of snap freezing in dry ice and
thawing before a final 30 s sonication. Samples were incu-
bated at 60°C for 2 hours and then spun down at 4000 ×
g for 12 min. Supernatants were collected for myeloperox-
idase assay. Enzyme activity was assessed photometrically
at 630 nm. The assay mixture consisted of 20 µl
supernatant, 10 µl tetramethylbenzidine (final concentra-
tion 1.6 mM) dissolved in DMSO, and 70 µl H2O2 (final
concentration 3.0 mM) diluted in 80 mM phosphate
buffer pH 5.4.
Hydroperoxide assay
Tissue samples were homogenized and lipid hydroperox-
ides were extracted with a mixture of sample:Metha-
nol:Chloroform 1:1:2. The chloroform extract was
carefully collected and used to measure the hydroperoxide
concentration with a commercially available assay kit
from Cayman Chemical (Ann Arbor, MI).
High density oligonucleotide microarrays
Mice p8+/+ and p8-/- were injected with 70 mg/kg of LPS
(Salmonella thyphosa, Sigma) or saline. Animals were sacri-
ficed after 12 hr and liver recovered and stored at -80°C
before RNA extraction. Total RNA was prepared from liver
using the Trizol reagent (Life Technologies). Twenty µg of
total RNA was converted to cDNA with SuperScript reverse
transcriptase (Gibco-BRL), using T7-oligo-d(T)24  as a
primer. Second-strand synthesis was performed using T4
DNA polymerase and E. Coli DNA ligase followed by
blunt ending by T4 polynucleotide kinase. cDNA was iso-
lated by phenol-chloroform extraction using phase lock
gels (Brinkmann). cDNA was in vitro transcribed using the
T7 BioArray High Yield RNA Transcript Labeling Kit (Enzo
Biochem, New York, N.Y.) to produce biotinylated cRNA.
Labelled cRNA was isolated using an RNeasy Mini Kit col-
umn (Qiagen). Purified cRNA was fragmented to 200–
300 mer cRNA using a fragmentation buffer (100 mM
potassium acetate-30 mM magnesium acetate-40 mM
Tris-acetate, pH 8.1), for 35 min at 94°C. The quality of
total RNA, cDNA synthesis, cRNA amplification andBMC Gastroenterology 2003, 3 http://www.biomedcentral.com/1471-230X/3/25
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cRNA fragmentation was monitored by micro-capillary
electrophoresis (Bioanalizer 2100, Agilent Technologies).
The cRNA probes were hybridized to an Mu11K oligonu-
cleotide arrays (Affymetrix, Santa Clara, CA). The Mu11K
oligonucleotide arrays represents ~6,000 sequences of
mouse Unigene that have been functionally characterized
and ~6,000 sequences ESTs clusters. Each sequence in the
chip is represented by 32 probes : 16 "perfect match"
(PM) probes that are complementary to the mRNA
sequence and 16 "mismatch" (MM) probes that only dif-
fer by a single nucleotide at the central base (more
detailed information about the Mu11K oligonucleotide
arrays can be obtained in the web site http://www.affyme
trix.com). Fifteen micrograms of fragmented cRNA was
hybridized for 16 h at 45°C with constant rotation (60
rpm). Microarrays were processed in an Affymetrix
GeneChip Fluidic Station 400. Staining was made with
streptavidin-conjugated phycoerythrin (SAPE) followed
by amplification with a biotinylated anti-streptavidin
antibody and a second round of SAPE, and then scanned
using an Agilent GeneArray Scanner (Agilent Technolo-
gies). Expression value (signal) is calculated using Affyme-
trix Genechip software MAS 5.0 (for fully description of
the statistical algorithms see http://affymetrix.com/sup
port/technical/whitepapers/sadd_whitepaper.pdf).
Briefly, signal is calculated as follow : First, probe cell
intensities are processed for global background. Then,
MM value is calculated and subtracted to adjust the PM
intensity in order to incorporate some measure of non-
specific cross-hybridization to mismatch probes. Then,
this value is log-transformed to stabilize the variance. Sig-
nal is output as the antilog of the resulting value. The 20
probe pairs representing each gene are consolidated into a
single expression level. Finally, software scales the average
intensity of all genes on each array within a data set. Final
value of signal is considered representative of the amount
of transcript in solution.
Housekeeping controls β-actin and GAPDH genes serve as
endogenous controls and are useful for monitoring the
quality of the target. Their respective probe sets are
designed to be specific to the 5', middle, or 3' portion of
the transcript. The 3'/5' signal ratio from these probe sets
is informative about the reverse transcription and in vitro
transcription steps in the sample preparation. Then, an
ideal target in which all transcripts was full-length tran-
scribed would have an identical amount of signal 3' and
5' and the ratio would be equal to 1. Differences greater
than three fold between signal at 3' and 5' for these
housekeeping genes indicate that RNA was incompletely
transcribed or target may be degraded. Ratio of fluorescent
intensities for the 5' and 3' ends of these housekeeping
genes was <2.
Hybridization experiments were repeated twice using
independent cRNA probes synthezised with RNA from
two independent livers. Genes were considered as differ-
entially expressed when both hybridizations showed >2
folds change. Data presented in this work represent the
average of both hybridizations.
RT-PCR analysis
Total RNA (1 µg) was analyzed by RT-PCR with the Super-
Script™ One-step RT-PCR System and the Platinum Taq kit
(Life Technologies). RT-PCR was performed using differ-
ent numbers of cycles to verify that the conditions chosen
were within the linear range. The mRNA coding for p8 was
specifically amplified with sense
(5'GAAGCTGCTGCCAATACCAACC3') and antisense
(5'TAGCTCTGCCCGTCTACCCTC3') primers, in posi-
tions 181 and 540 of the cDNA (accession # AF131196),
respectively. The mRNA coding for HMG1 was specifically
amplified with sense
(5'GGGACTATTAGGATCAAGCAATC3') and antisense
(5'CCTAAACTAAGCAGATTAAGG3') primers, in posi-
tions 1501 and 1987 of the cDNA (accession # Z11997),
respectively. As control, the transcript coding for the ribos-
omal protein RL3 was specifically amplified for 22 cycles
with sense (5'GAAAGAAGTCGTGGAGGCTG3') and anti-
sense (5'ATCTCATCCTGCCCAAACAC3') primers, in
positions 216 and 637 of the cDNA, respectively (acces-
sion # NM_013762).
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